Julie Ann Justo to Humans
This is a "connection" page, showing publications Julie Ann Justo has written about Humans.
Connection Strength
0.393
-
How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2022 05 15; 74(Suppl_3):e23-e33.
Score: 0.032
-
Ignoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria? Clin Infect Dis. 2019 04 08; 68(8):1431.
Score: 0.025
-
Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979.
Score: 0.024
-
Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
Score: 0.023
-
Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
Score: 0.023
-
Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjects. Antimicrob Agents Chemother. 2015 Jul; 59(7):3956-65.
Score: 0.019
-
Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials. Clin Infect Dis. 2014 Oct 15; 59 Suppl 3:S162-9.
Score: 0.019
-
Adverse reactions associated with systemic polymyxin therapy. Pharmacotherapy. 2015 Jan; 35(1):28-33.
Score: 0.019
-
Commentary on "incidence and predictors of vancomycin-associated nephrotoxicity". South Med J. 2014 Jun; 107(6):389-90.
Score: 0.018
-
Evaluation of the Infectious Diseases Society of America's Core Antimicrobial Stewardship Curriculum for Infectious Diseases Fellows. Clin Infect Dis. 2022 03 23; 74(6):965-972.
Score: 0.008
-
Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection. Infection. 2022 Aug; 50(4):873-877.
Score: 0.008
-
Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score. J Infect. 2022 02; 84(2):131-135.
Score: 0.008
-
Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study. Int J Antimicrob Agents. 2021 Dec; 58(6):106453.
Score: 0.008
-
Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders Through Curriculum Development and Dissemination. Clin Infect Dis. 2021 09 07; 73(5):911-918.
Score: 0.008
-
An experiential learning collaborative on quality improvement for interprofessional learners. J Interprof Care. 2022 Mar-Apr; 36(2):327-330.
Score: 0.007
-
Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap. Infect Control Hosp Epidemiol. 2021 05; 42(5):622-624.
Score: 0.007
-
Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature. Int J Antimicrob Agents. 2020 Nov; 56(5):106158.
Score: 0.007
-
Regional and statewide antibiograms as targeted interventions against antibiotic resistance. Infect Control Hosp Epidemiol. 2021 04; 42(4):503-505.
Score: 0.007
-
Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location. Infect Control Hosp Epidemiol. 2020 08; 41(8):879-882.
Score: 0.007
-
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper. Pharmacotherapy. 2020 04; 40(4):368-371.
Score: 0.007
-
Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
Score: 0.007
-
Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study. Infection. 2020 Feb; 48(1):129-132.
Score: 0.007
-
Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
Score: 0.007
-
Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
Score: 0.006
-
Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents. Am J Infect Control. 2019 11; 47(11):1284-1289.
Score: 0.006
-
Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
Score: 0.006
-
Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need. Clin Infect Dis. 2018 09 28; 67(8):1285-1287.
Score: 0.006
-
Preventing the Post-Antibiotic Era by Training Future Pharmacists as Antimicrobial Stewards. Am J Pharm Educ. 2018 08; 82(6):6770.
Score: 0.006
-
Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
Score: 0.006
-
Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284.
Score: 0.006
-
Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
Score: 0.006
-
Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
Score: 0.006
-
Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
Score: 0.005
-
Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
Score: 0.005
-
Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
Score: 0.005
-
Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
Score: 0.005
-
Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
Score: 0.005
-
Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
Score: 0.005
-
Staphylococcus aureus infection of the optic nerve. J Neuroophthalmol. 2015 Mar; 35(1):48-50.
Score: 0.005